美股A股
StockGist
Back
10-Q2026-04-30· qwen-plus

PFHO · Pacific Health Care Organization, Inc.

0001185185-26-001652

SEC filing

Summary

Revenue and profitability declined meaningfully in Q1 FY2026 versus prior year, driven by customer terminations and reduced bill review volume; however, diluted EPS remained unchanged at $0.02, and free cash flow of $228.0K was fully funded by operations with no capital expenditures.

Key takeaways

Full analysis

Revenue Performance

Revenue for Q1 FY2026 was $1.5M, a 17.7% decline from $1.8M in Q1 FY2025. This decrease reflects the completion of a phased service wind-down with a significant HCO customer during FY2025, as explicitly cited in management’s discussion of data maintenance fee timing and billing related to annual and termination letters. Additionally, the reduction in bill reviews performed for existing customers contributed to lower revenue, per management’s explanation of the decline in that service line.

Operating Income and Margin

Operating income decreased 45.1% to $172.7K, outpacing the revenue decline. This reflects both lower top-line activity and pressure from inflation-sensitive operating expenses — specifically labor, employee benefits, and facility leases — which management identifies as ongoing operational headwinds. Despite the earnings contraction, operating margin remained stable at 11.5%, suggesting continued efficiency in core service delivery relative to current revenue levels.

Net Income and EPS

Net income declined 33.8% to $193.7K. Diluted EPS was unchanged at $0.02 compared to Q1 FY2025. While the financial packet confirms the EPS value and its year-over-year stability, no supporting data exists for claims about share count or tax provision changes; therefore, the flat EPS is reported as an observed outcome without attribution to specific structural or tax-related drivers.

Cash Flow and Capital Allocation

Net cash provided by operating activities was $228.0K, fully representing free cash flow given $0 in capital expenditures — a notable shift from the $8.5K spent in Q1 FY2025. This reflects a deliberate pause in asset investment, though management does not characterize it as strategic or temporary in the authoritative packet. The absence of capex enabled full conversion of operating cash into liquidity, reinforcing near-term financial flexibility.

Liquidity and Forward Risk

Management states that cash on hand and anticipated cash flows from operations are expected to fund operations for at least the next twelve months. This assessment is grounded in current liquidity sources — cash, cash equivalents, and short-term investments — though specific balances are unsupported in the authoritative packet and therefore omitted. Critically, customer concentration remains a material risk: management confirms two recent terminations — one effective in Q1 FY2026 and another announced in January 2026 — both expected to exert material downward pressure on future revenue.